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Abstract
Cell-permeable peptides were evaluated for a quantitatively controlled import of small molecules. The dependence of the import
efficiency on the fluorophore, on the position of the fluorophore as well as on the nature of the cargo were addressed. Cellular uptake was
quantitated by flow cytometry and fluorescence correlation microscopy (FCM). Fluorophores with different spectral characteristics, covering
the whole visible spectral range, were selected in order to enable the simultaneous detection of several cell-permeable peptide constructs. The
transcytosis sequences were based either on the sequence of the Antennapedia homeodomain protein (AntpHD)-derived penetratin peptide or
the Kaposi fibroblast growth factor (FGF)-derived membrane translocating sequence (MTS)-peptide. In general, the AntpHD-derived
peptides had a three- to fourfold higher import efficiency than the MTS-derived peptides. In spite of the very different physicochemical
characteristics of the fluorophores, the import efficiencies for analogues labelled at different positions within the sequence of the import
peptides showed a strong positive correlation. However, even for peptide cargos of very similar size, pronounced differences in import
efficiency were observed. The use of cell-permeable peptide/cargo constructs for intracellular analyses of structure–function relationships
therefore requires the determination of the intracellular concentrations for each construct individually.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cell-permeable peptides cross the plasma membrane in a
receptor- and energy-independent manner [1,2]. These mol-
ecules were either derived from the hydrophobic sequences
of signal peptides, such as the Kaposi fibroblast growth
factor (FGF)-derived membrane-translocating sequence
(MTS) [3], or from insect proteins, such as the third helix
of the DNA-binding domain of the Antennapedia homeo-
domain protein (AntpHD) [2]. While the former is a highly
hydrophobic sequence with 8 out of 16 amino acids being
valine and leucine residues and the remainder either alanine
or proline, the latter is basic with 7 out of 16 residues being
arginine or lysine.
Covalent or noncovalent [4] linkage of cell-permeable
peptides to other molecules mediates the noninvasive import
of these cargo molecules into cells ex vivo, as well as in
whole animals [5,6]. Such cargo have been peptides [7,8],
oligonucleotides [4], as well as proteins as large as 120 kDa
[6,9]. The capacity to mediate entry of impermeable mole-
cules into cells renders cell-permeable peptides a valuable
tool in the early stages of the drug development process.
Import of inhibitors may serve to identify and validate
intracellular molecules as targets for achieving a desired
therapeutic outcome [10]. Substances exhibiting biological
activity for isolated molecules in vitro, but unfavourable
pharmacokinetic properties for in vivo tests, may be rendered
cell-permeable. Fusion of cell-permeable peptides to anti-
sense-oligonucleotides has been employed for suppressing
the expression of certain proteins [11]. Peptide conjugates
have served as pseudo-substrates, competitive inhibitors of
the enzyme active site or structural mimics of the interaction
domain [12]. The advantages of peptide-based approaches
are the accessibility of large collections of different com-
pounds by well-established automated procedures, as well as
the generation of active compounds based on available
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structural information of interaction domains. Structure–
function relationships of intracellular interaction domains
have been analysed by testing a series of different peptides
fused to a cell-permeable moiety [13].
If the import efficiency of cell-permeable constructs is
cargo-dependent, the determination of the intracellular con-
centrations for each of the cell-permeable peptide/cargo
constructs is mandatory, particularly in the analysis of
structure–function relationships. Otherwise, differences in
a biological response may simply reflect differences in
uptake efficiency. Fluorescent derivatization of cell-perme-
able peptides provides a sensitive and specific quantitative
read-out on intracellular peptide concentration using estab-
lished techniques such as flow cytometry. In addition, the
analysis of the subcellular distribution of cell-permeable
peptide/cargo constructs by fluorescence microscopy ena-
bles the identification of cellular compartments targeted by a
cell-permeable construct. Attaching the fluorescent reporter
group to the cell-permeable moiety minimizes the risk of
interference of the fluorescent label with the activity of the
cargo. By means of chemical ligation [14] or disulfide
linkage [15], cell-permeable peptides or fluorescent ana-
logues of these peptides may be used as building blocks for
rendering molecules cell-permeable.
To date, however, fluorescent labelling of cell-permeable
peptides has been limited to N-terminal derivatization of
peptides either with fluorescein as described for example in
Refs. [16,17] or NBD (7-nitrobenz-2-oxo-1,3-diazol-4-yl)
[18]. The import of cell-permeable constructs into cells
expressing GFP fusion proteins, as well as the simultaneous
detection of several different cell-permeable constructs,
requires the identification of spectrally distinct fluorophores
compatible with import. For this purpose, it needs to be
determined to which degree reporter groups with different
physicochemical characteristics influence the import char-
acteristics of the cell-permeable constructs. A fluorescein
reporter group, for example, carries negative charge, while a
tetramethylrhodamine (TAMRA) reporter group is zwitter-
ionic. Positive charge as well as hydrophobicity were
identified as important physicochemical determinants for
import efficiency for the AntpHD peptide [2,19]. It was
therefore to be expected that the import efficiency of the
transcytosis sequences should be affected by the physico-
chemical characteristics of the fluorophore. Furthermore,
fluorescent analogues carrying the fluorophore at a residue
within the peptide rather than at the N terminus are still
missing. Such analogues would enable the N-terminal
modification of cell-permeable peptides with cargo mole-
cules by solid phase synthesis. In addition, the introduction
of one fluorophore within the transcytosis peptide and a
second reporter group within the cargo would enable the
tuning of the spectral characteristics of double-labelled
constructs for fluorescence resonance energy transfer
(FRET) [20]. Such molecules are valuable tools for the
intracellular monitoring of, e.g. kinase [21] or protease
activity [22].
In order to establish fluorescently labelled cell-perme-
able peptides as pharmacokinetic modifiers for small mol-
ecules, the impact of a fluorescent tag on the ability of the
cell-permeable peptide to cross the plasma membrane was
addressed. For this purpose, sets of analogues labelled with
different fluorophores were generated by solid-phase pep-
tide synthesis. Fluorophores were attached to the side
chain of lysine residues introduced at different positions
within the peptide sequence, and the effect of different
fluorophores on import was compared.
For both the AntpHD and MTS peptides, internally
labelled analogues were identified with import efficiencies
equivalent to the N-terminally labelled peptides. Surpris-
ingly, the relative import efficiencies of peptides labelled
either with fluorescein or TAMRA at the N terminus or within
the peptide showed a strong positive correlation. This corre-
lation of import efficiencies for fluorescein- and TAMRA-
labelled cell-permeable peptide analogues demonstrates that
the capacity for import resides within the structure of the
peptide, and is little affected by the physicochemical charac-
teristics of the fluorophore. This finding was confirmed by
fluorescence correlation microscopy (FCM) [23] of fluores-
cein- and TAMRA-labelled peptides at lower nanomolar
concentrations.
The spectral range of flourescent analogues was extended
to the near infra-red by conjugation of an indocyanine dye
with Cy5-like [24] spectral characteristics. Import of three
different cell-permeable peptide analogues was simultane-
ously detected by confocal laser scanning microscopy of
living cells.
Finally, the dependence of import on the cargo was
addressed for small peptide cargos. Perez et al. [25] have
presented one example, in which for one out of three
structurally related constructs, import was completely abro-
gated. A thorough quantitative analysis of import efficien-
cies for small peptide cargos has been missing, however. For
this purpose a panel of different cargo peptides of 8 to 10
amino acids in length, as well as peptides with free or
amidated C termini were synthesized. The uptake ratios of
these molecules differed by factors of up to 8. These
findings underscore the need for an individual determination
of intracellular concentrations in applications, such as the
intracellular analysis of structure–function relationships and
target validation. The results presented in this paper validate
fluorescence as the analytical method of choice for these
measurements.
2. Materials and methods
2.1. Peptide synthesis
Peptides were synthesized in a 15-Amol scale by solid-
phase Fmoc-chemistry on an automated peptide synthesizer
for multiple peptide synthesis (RSP5032, Tecan, Hombrecht-
likon, Switzerland). Fmoc-protected amino acids were pur-
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chased from Novabiochem (Heidelberg, Germany) and
Fmoc-protected 8-amino-3,6-dioxaoctanoic acid (Ado) from
Neosystem (Strassburg, France). Standard chemicals in pep-
tide chemistry were obtained from Fluka (Deisenhofen,
Germany) and Merck (Darmstadt, Germany), solvents were
p.a. grade. The peptides were synthesized as free acids on a
Cl–Trityl resin (capacity 0.5 mmol/g; Senn Chemicals,
Dielsdorf, Switzerland) and as amides on Rink–amide resin
(capacity 0.7 mmol/g; Senn Chemicals). The amino acid
sequence of the AntpHD peptide was RQIKIWFQ-
NRRMKWKK and of the MTS peptide AAVALLPAVL-
LALLAP. The MTS peptide was extended at its N and/or C
termini with one Ado building block to increase its water
solubility.
The resin-bound peptides were labelled at the N terminus
in the presence of 5 equivalents of either 5(6)-carboxyfluor-
escein (Fluo; Fluka) or 5(6)-carboxytetramethylrhodamin
(TAMRA; Fluka), and 5 equivalents of each N-hydroxy-
benzotriazole (HOBt) and diisopropylcarbodiimide (DIC) in
dimethylformamide (DMF) twice for 20 h.
N-terminal labelling of the resin-bound AntpHD-peptide
with the free carboxylic acid of the S0387 fluorophore was
carried out in the presence of 2 equivalents of S0387 (FEW
chemicals, Wolfen), 5 equivalents HOBt and 5 equivalents
DIC in DMF twice for 20 h.
Conjugation of fluorophores to the q-amino group of
lysine side chains was carried out via incorporation of
Fmoc-Lys(Dde)-OH (Calbiochem-Novabiochem, Bad
Soden, Germany) as a building block in peptide syn-
thesis. After Fmoc-deprotection of the amino terminus of
the resin-bound peptide with piperidine/DMF, the N-
terminal amino group was blocked by acetylation (acetic
anhydride/diisopropylethylamin/DMF (1:1:8), 230 min).
Deprotection of the Dde protecting group was performed
by treatment with 2% hydrazine monohydrate in DMF (v/
v) twice for 3 min. The coupling of the fluorophore
followed the same protocol as the one for N-terminal
labelling.
The peptides were cleaved off the resin by treatment
with 92.5% trifluoroacetic acid (TFA), 2.5% triisopropyl-
silane (TIPS), 2.5% ethanedithiole and 2.5% H2O twice
for 2 h each. The peptides were precipitated by addition
of diethylether (20 jC). Precipitated peptides were
washed twice with cold ether. Finally, the peptides were
dissolved in tertiary butanol (tBuOH)/H2O, 4:1, and
lyophilized.
The peptides were analysed by analytical reverse phase
chromatography (RP)-HPLC using an H2O (0.1% TFA)/
acetonitrile (0.1% TFA) gradient on a Waters 600 System
(Eschborn, Germany) with detection at 214 nm and
by Maldi-TOF mass spectrometry (Hewlett-Packard
G2025A). Peptides were purified by preparative RP-HPLC
(Nucleosil 300 C18 column, 5 Am particle diameter,
25020 mm; Grom, Herrenberg, Germany) on a Waters
600 Multisolvent Delivery System using optimized gra-
dients.
2.2. Determination of concentrations of fluorescently
labelled peptides by UV/VIS spectroscopy
Peptides were dissolved in dimethylsulfoxide (DMSO)
to about 20 mg/ml. For the determination of the concen-
tration, these stock solutions were diluted 1:10 in ddH2O.
This solution was further diluted 1:100 in 0.1 M Tris–
HCl pH 8.8 and the absorbance measured. The concen-
trations of the stock solutions were calculated assuming
ecarboxyfluorescein 492 nm=75,000 l/(molcm). TAMRA-
labelled peptides dissolved in DMSO to about 20 mg/ml
were diluted 1:10 in ddH2O followed by a 1:100 dilution
in methanol. The concentrations of the methanol solu-
tions were calculated assuming eTAMRA 540 nm=95,000 l/
(molcm). The concentration of the S0387-labelled peptide
was adjusted by measurement of the concentration by
FCM.
2.3. Cell culture
The adherent, melanoma-derived SKMel 37 cell line was
grown in a 5% CO2 humidified atmosphere at 37 jC in
Dulbecco’s Modified Eagle’s medium (DMEM) with GLU-
TAMAX I, 25 mM HEPES, 4500 mg/l D-glucose, pH 7.2
(Invitrogen, Karlsruhe, Germany), supplemented with 10%
fetal calf serum (PAN Biotech, Aidenbach, Germany), 100
U/ml penicillin, and 0.1 mg/ml streptomycin (Boehringer,
Mannheim, Germany). Cells were passaged by trypsiniza-
tion with trypsin/EDTA 0.05/0.02% (w/v) in phosphate-
buffered saline (PBS; Biochrom, Berlin, Germany) every
third to fourth day. For growth in chambered coverglasses
(Nunc, Wiesbaden, Germany), cells were seeded at a density
of 25,000/cm2 and used for FCM measurements at a conflu-
ency of approximately 75%.
2.4. Flow cytometry
SKMel 37 cells were seeded at a density of 80,000 per
well in 24-well plates (Sarstedt, Nu¨mbrecht) in 400-Al
serum-containing medium. One day later, the cells were
washed with serum-free medium and incubated in 200-Al
serum-free medium. After 2 h, peptides were added in
concentrations as indicated in Section 3. Each condition
was tested in duplicate. After a 2-h incubation, cells were
washed with PBS and trypsinized. The cells were sus-
pended in PBS containing 0.1% (w/v) BSA and 5 mM
glucose. Samples were kept on ice and measured immedi-
ately. The fluorescence of 5000 vital cells was acquired.
Vital cells were gated based on sideward scatter and
forward scatter. For the determination of nonspecific
uptake of fluorescein-labelled peptides, the peptide Fluo-
Ahx-SFHTMSAAKLI-NH2 (Ahx, 6-aminohexanoic acid)
was added in the same concentration as were the MTS or
AntpHD analogues. This peptide was previously designed
as a peptide ligand for the HLA-DRB1*1501 MHC class
II molecule [26]. It was selected because of the different
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physicochemical side-chain characteristics and its very
different biological relevance.
2.5. FCM
FCM measurements were carried out on a ConfoCor2
fluorescence correlation microscope (Carl Zeiss, Jena),
equipped with a SensiCam cooled 12-bit CCD camera
(PCO Computer Optics, Kelheim, Germany). For image
acquisition by whole-field epifluorescence microscopy, a
filter set consisting of an HQ470/40 excitation filter, a
Q495LP beam splitter, and an HQ525/50 detection filter
(AHF Analysentechnik, Tu¨bingen, Germany) was used for
imaging of fluorescein. A combination of an HQ548/10
excitation filter, a Q565LP beamsplitter, and an HQ610/75
detection filter were employed for imaging of TAMRA-
labelled samples. For FCM measurements of fluorescein-
labelled peptides, the 488-nm line of an argon ion laser was
reflected into the sample via an HFT488 beam-splitter and
fluorescence detected with a 500–550-nm band-pass filter.
Fluorescence of TAMRA-labelled peptides was excited with
a 543 HeNe-laser and detected with an HFT 488/543 beam-
splitter in combination with a BP 560–615 detection filter.
For positioning along the optical axis, the z-scan option of the
ConfoCor2 software was employed. Profiles of fluorescence
along the optical axis were acquired at 0.4 kW/cm2 (for both
laser lines) at a resolution of 0.5 Am per step. Z-scans were
saved by screen capture from the computer screen. The
position of the detection volume in the x- and y-dimensions
was determined by bleaching a film of fluorescein adsorbed
to the surface of a microscope slide and determining the
position of the bleached spot in an epifluorescence image.
Positioning in x and y was based on real-time transmission
images acquired by the CCD camera using a motorized stage.
A series of five subsequent autocorrelation measurements
was carried out over 30 s each, for every data point. Laser
intensities were 40 kW/cm2 for fluorescein and 16 kW/cm2
for TAMRA. The individual autocorrelation functions were
fitted one by one and those unaffected by initial photo-
bleaching included for averaging.
Reference measurements were carried out for carboxy-
fluorescein, TAMRA, Fluo-AntpHD, Fluo-MTS, and the
corresponding TAMRA-labelled peptides at concentrations
of 25 and 75 nM in Hepes-buffered saline (HBS; 135 mM
NaCl, 10 mM KCl, 0.4 mM MgCl2, 1 mM CaCl2, 10 mM
Na–Hepes, pH 7.4), supplemented with 0.1% BSA and 5
mM glucose in chambered coverglasses without cells in a
volume of 400 Al.
For the determination of import efficiencies, the cells
were incubated with the fluorescently-labelled peptide in
HBS, 0.1% BSA, 5 mM glucose in a volume of 400 Al. The
respective concentrations were as indicated in the figures.
After 1 h of incubation at 37 jC, FCM measurements were
started at room temperature. Autocorrelation functions were
recorded in the nucleus and in the buffer next to each cell. A
minimum of eight cells was analysed for each condition.
Autocorrelation functions were fitted with the built-in rou-
tines of the ConfoCor2 software.
2.6. Confocal laser scanning microscopy
Confocal laser scanning microscopy was performed on
an inverted LSM510 laser scanning microscope (Carl Zeiss,
Go¨ttingen, Germany) equipped with a Plan-Apochromat
631.4 N.A. lens. Triple detection of fluorescein, TAMRA,
and S0387-labelled peptides was performed using a filter set
consisting of an HFT UV/488/543/633 beam splitter in
combination with an NFT 545 beam splitter and a BP
505–530 band pass filter for fluorescein detection, an
NFT 635 VIS beam splitter and a BP 560–615 detection
filter for TAMRA detection, and an LP650 long pass filter
for S0387-detection. To avoid cross-talk detection, the
multi-track modality of the LSM was employed for image
acquisition. Live cells were measured in chambered cover-
slips as in FCM measurements.
3. Results
Fluorescently labelled cell-permeable peptides were
established as pharmacokinetic modifiers in intracellular
target validation. For this purpose, the import capacity
was compared for cell-permeable peptide analogues labelled
with fluorophores at different positions along the peptide.
Moreover, the dependence of import on the peptide cargo
was determined. All peptides were generated by solid phase
peptide synthesis and purified by preparative HPLC. Import
of peptides into the human melanoma cell line SKMel 37
was quantitated in living cells after trypsinization by flow
cytometry. FCM, as well as confocal laser scanning micro-
scopy, were employed to fully interpret the results obtained
by flow cytometry.
3.1. Internally labelled fluorescent analogues
To this end, import of cell-permeable peptides had only
been observed for peptides labelled with fluorophores at
their N terminus. In order to extend the range of fluores-
cently labelled cell-permeable peptides, analogues derivat-
ized with a fluorophore within the peptide sequence were
generated. The availability of such compounds would (i)
significantly increase the options for the generation of
doubly labelled cell-permeable peptide constructs and (ii)
enable the N-terminal extension of fluorescently labelled
cell-permeable peptides with cargo. Analogues were gen-
erated for both the AntpHD and MTS peptides. The uptake
efficiencies were compared and the effect of different
fluorophores on translocation properties addressed.
For both transcytosis peptides, series of analogues were
synthesized in which one out of four consecutive residues in
the central portion of the peptide was replaced by a lysine
residue derivatized with carboxyfluorescein via its q-amino
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group (Table 1). Relative import efficiencies into adherently
growing SKMel 37 cells were determined by flow cytom-
etry. As reported earlier for measurements by FCM [27],
import of the N-terminally labelled AntpHD analogue was
about 3 times that of the corresponding MTS analogue (Fig.
1). The relative import efficiencies were highly reproduci-
ble. Except for the fluorescein-labelled A12K(Fluo) MTS
analogue, fluorescent derivatization within the MTS peptide
reduced the import efficiency to the levels of unspecific
binding and pinocytic uptake of a fluorescein-labelled con-
trol peptide. The import efficiency of the A12K(Fluo)
analogue was about 85% that of the N-terminal analogue.
For the AntpHD peptide as well, one analogue (N9K(Fluo))
was imported as efficiently as the N-terminal analogue,
while the other three fluorescein derivatives showed greatly
reduced import efficiencies. For the Q8K(Fluo) analogue,
import was reduced by 50% and nearly completely abol-
ished for the other two analogues.
3.2. Effect of the fluorophore on import efficiency
So far, fluorescent labelling of cell-permeable peptides
has been limited to the introduction of fluorophores
emitting in the short-wavelength visible part of the spec-
trum. Fluorophores emitting in the orange to far red
spectral range are highly desirable for the elimination of
autofluorescence [28] and for the detection of cell-perme-
able peptides in the presence of GFP fusion proteins. The
fluorophore tetramethylrhodamine (TAMRA) was selected
based on its compatibility with solid phase peptide syn-
thesis, price, high photostability, and spectral compatibility
with fluorescein and Cy5-like dyes for simultaneous
detection. A subset of TAMRA-labelled analogues was
synthesized and import quantitated by flow cytometry
(Fig. 2A). In contrast to fluorescein carrying one negative
charge at neutral pH, TAMRA is a zwitterionic compound
with a neutral net charge. Earlier analyses of structure–
function relationships of cell-permeable peptides had
stressed the significance of the physicochemical character-
istics of the transcytosis sequence [16]. Negative, within
the cell-permeable peptide charge, in particular, was
shown to be incompatible with import [29]. In comparison
to fluorescein, it was therefore suspected that TAMRA
would significantly promote import.
As for the fluorescein analogue, full import capacity
was observed for the MTS A12K(TAMRA) and AntpHD
N9K(TAMRA) variants, while import was abolished for
the MTS L10K(TAMRA) analogue. In contrast to the
fluorescein derivatives, import of AntpHD F7K(TAMRA)
was reduced by only 50%. The relative import efficien-
cies for the fluorescein-labelled constructs showed a
strong positive correlation with those of the TAMRA-
labelled constructs (Fig. 2B). In spite of the differences in
the physicochemical characteristics of the dyes, derivati-
zation of individual residues affected import in a similar
way, independent of the dye. Measurements of intra-
cellular concentrations by FCM (see below) revealed that
import of the N-terminally labelled TAMRA-labelled
peptides was more efficient by a factor of 1.5 than that
of the respective fluorescein-labelled peptides. Consider-
ing the positive correlation of import efficiencies, the
TAMRA reporter group affected import of all analogues
in a similar fashion.
3.3. Concentration independence of peptide import
The concentration independence of import is a vital
prerequisite for the analysis of intracellular dose–response
characteristics using cell-permeable peptide cargo-con-
structs. To date, however, the analysis of import has been
limited to the micromolar range. Recently, the authors
presented intracellular concentration measurements of fluo-
rescein-labelled cell-permeable peptides in the nanomolar
Table 1
Name and sequence of carboxyfluorescein-labelled AntpHD and MTS
analogues
Name Sequence
AntpHD WT(Fluo)* Fluo-RQIKIWFQNRRMKWKK
AntpHD W6K(Fluo) Ac-RQIKIK(Fluo)FQNRRMKWKK
AntpHD F7K(Fluo)* Ac-RQIKIWK(Fluo)QNRRMKWKK
AntpHD Q8K(Fluo) Ac-RQIKIWFK(Fluo)QNRRMKWKK
AntpHD N9K(Fluo)* Ac-RQIKIWFQK(Fluo)NRRMKWKK
MTS WT(Fluo)* Fluo-AAVALLPAVLLALLAP-Ado-A
MTS V9K(Fluo) Ac-Ado-AAVALLPAK(Fluo)LLALLAP-Ado-A
MTS L10K(Fluo)* Ac-Ado-AAVALLPAVK(Fluo)LALLAP-Ado-A
MTS L11K(Fluo) Ac-Ado-AAVALLPAVLK(Fluo)ALLAP-Ado-A
MTS A12K(Fluo)* Ac-Ado-AAVALLPAVLLK(Fluo)LLAP-Ado-A
Those peptides marked with an asterisk were also synthesized as
carboxytetramethylrhodamine-labelled analogues. ‘Ac’ denotes an N-
terminal acetylation, Ado represents an 8-amino-3,6-dioxaoctanoic acid
building block. All peptides were synthesized as free acids.
Fig. 1. Relative import efficiencies of carboxyfluorescein-labelled cell-
permeable peptides. Given are the means for two independent experiments.
The experiments were normalized based on the total fluorescence of both
experiments. As a control for unspecific peptide binding, the amidated
peptide Fluo-Ahx-SFHTMSAAKLI was used. Adherently growing SKMel
37 cells were incubated with peptides at a concentration of 4 AM at 37 jC
for 2 h followed by trypsinization and flow cytometry.
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range by FCM [27]. In contrast to other techniques, FCM
allows for a direct determination of molecule numbers. Due
to the minuteness of the confocal detection volume (sub-
femtoliter), intracellular measurements can be conducted
with peptide present in the incubation buffer outside the cell.
Cellular import of analogues labelled at the N terminus
was measured by FCM at lower nanomolar concentrations.
Import of peptides was compared by calculating the parti-
tion coefficients as the ratio of the number of molecules in
the nucleus and in the incubation buffer (Fig. 3). The
TAMRA-labelled peptides were imported more efficiently
than the fluorescein-labelled peptides by a factor of 1.5
(Fig. 4A). The application of FCM is limited to the
subnanomolar to lower nanomolar concentration range.
For this reason, it was impossible to compare the import
efficiencies at nanomolar concentrations directly with those
at micromolar concentrations. Instead, the relative import
efficiencies of fluorescein and TAMRA-labelled MTS and
AntpHD peptides determined by flow cytometry (Fig.
4B,C) were compared with those determined by FCM
(Fig. 4D). The larger standard deviations of the FCM data
result from the fact that this number is the ratio of the
number of molecules inside and outside the cell. A total of
at least 30 measurements in eight different cells were
included for each condition. The higher standard deviations
of the MTS peptides are explained by the stronger adsorp-
tion to the bottom of the measurement chamber which had
to be compensated for in order to determine the intracellular
molecule number. A detailed presentation of these intra-
cellular concentration measurements can be found in the
publication by Waizenegger et al. [27]. The relative import
efficiencies determined by both methods closely matched
one another. If import for either one peptide was concen-
tration-dependent, this correspondence of import efficien-
cies would be very unlikely. This result, therefore, strongly
supports a concentration independence of import covering
the lower nanomolar to the lower micromolar range. Except
for the TAMRA-labelled AntpHD analogue, all partition
coefficients were significantly smaller than 1 (Fig. 4A), i.e.
the concentration of the peptide inside the cells was lower
than the concentration outside. The peptide concentration in
the buffer therefore does not reflect the intracellular con-
centration; the latter depends on the peptide in each indi-
vidual case.
Fig. 2. Comparison of import efficiencies of carboxyfluorescein- and TAMRA-labelled cell-permeable peptide analogues. (A) Relative import efficiencies of
TAMRA-labelled peptide analogues. Adherent SKMel 37 tissue culture cells were incubated with peptide at a concentration of 4 AM for 2 h, trypsinized and
fluorescence measured by flow cytometry. (B) Correlation of import efficiencies of TAMRA- and carboxyfluorescein-labelled peptide analogues.
Fig. 3. Intracellular concentration measurements of cell-permeable peptides labelled at the N terminus with either fluorescein or TAMRA by fluorescence
correlation microscopy. (A) Intranuclear autocorrelation measurement of Fluo-AntpHD at a concentration of peptide in the buffer of 75 nM. The amplitude of
the autocorrelation function at s=0 s is inversely related to the number of molecules in the confocal detection volume. (B, C) FCM measurements of MTS and
AntpHD peptides labelled at the N terminus with either carboxyfluorescein (B) or TAMRA (C). The number of molecules were derived from two-component
fits to the autocorrelation functions and corrected for fluorescence originating from molecules adsorbed to the bottom of the measurement chambers. For MTS
peptides as well as for TAMRA-labelled AntpHD peptides, the molecule numbers in the buffer were lower than those of the fluorescein-labelled AntpHD
peptide due to stronger adsorption of the peptides to the walls and the bottom of the measurement chamber.
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3.4. Cargo dependence of import
In order to address the cargo dependence of import for
small peptide cargos in detail, N-terminally labelled
AntpHD analogues with C-terminal peptide cargos of
similar size were synthesized. Cargos were representative
for primary applications of cell-permeable peptide con-
structs. These were the Myc-tag peptide EQKLISEEDL, a
recently reported peptide inhibitor of the tyrosine kinase
ZAP-70 KLILFLLL [30], as well as the MHC class I-
Fig. 4. Concentration independence of import. (A) FCM-derived partition coefficients of cellular uptake calculated by dividing the number of molecules in the
nucleus by the number of molecules in the incubation buffer (see Fig. 3). (B, C) Import efficiencies for AntpHD and MTS peptides N-terminally labelled with
either carboxyfluorescein or TAMRA. (D) Comparison of relative import efficiencies of carboxyfluorescein- and TAMRA-labelled peptides determined by
FCM and flow cytometry. For FCM measurements, peptide concentrations were 75 nM for carboxyfluorescein and 25 nM for TAMRA-labelled peptides, and 2
and 4 AM for flow cytometry. In spite of these very different concentrations, the relative import efficiencies for AntpHD and MTS labelled peptides agreed with
each other.
Fig. 5. Cargo dependence of import. (A) Import of AntpHD-based constructs labelled with carboxyfluorescein at the N terminus. All peptides were synthesized
with a free C-terminal carboxyl-group. The N-terminal glycine residue for the ZAP-70 inhibitor peptide KLILFLLL was introduced as a spacer amino acid. (B)
Dependence of import on C-terminal amidation. Constructs were based on a truncated form of the AntpHD-sequence (tAntpHD) and the import of these
molecules was compared with the import efficiency of the full length AntpHD peptide. For the inhibitor construct, the C-terminal lysine residue of the import
peptide served as the first residue of the inhibitor. Cells were incubated with 2 AM peptide for 2 h. Peptides were synthesized either with a free carboxyl group
(-OH) or with an amidated C terminus (-NH2).
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binding T-lymphocyte epitope SIINFEKL [31]. The latter
two have already been employed in combination with
cell-permeable peptides [30,32].
Intracellular fluorescence of cells incubated with the
AntpHD-ZAP-70 inhibitor peptide for 2 h was five times
that of cells incubated with the AntpHD peptide, alone (Fig.
5A). In contrast to this, the C-terminal extension of the
AntpHD peptide with the Myc-tag decreased the intracel-
lular signal in comparison with the AntpHD peptide by
more than 50%. For the MHC epitope, the intracellular
signal was 3.5 times that of the AntpHD peptide.
The impact of minimal structural differences on import
was addressed by quantitating intracellular fluorescence for
pairs of peptides with either a free or amidated carboxy
terminus. The constructs were based on a recently described
truncated form of the AntpHD peptide comprising the C-
terminal eight amino acids NRRMKWKK only [16]. Car-
boxy-terminal amidation had a great impact on import
efficiency. Import of the amidated inhibitor construct was
seven times that of the construct with the free carboxy
terminus; import of the amidated truncated peptide alone
was 1.5 times that of the free acid. In contrast to the initial
report on the truncated peptide, in our hands this molecule
only translocated weakly. The truncated penetratin peptides
conjugated to the inhibitor peptide, however, exhibited a
translocation efficiency similar to the efficiency of the full-
length penetratin.
3.5. Triple labelling
The availability of cell-permeable peptides labelled with
spectrally distinct fluorophores affords the use of combina-
tions of different cell-permeable peptide/cargo constructs. In
this way, several molecular interactions may be addressed
simultaneously. To this end, only one cell-permeable peptide
cargo construct carrying one specific fluorophore has been
used at a time. To explore the possibility of simultaneously
detecting three cell-permeable constructs in one cell, a
further fluorescent analogue emitting fluorescence in the
near infra-red part of the spectrum was generated. Cells
were incubated with fluorescein-labelled, TAMRA-labelled,
and S0387-labelled AntpHD peptides and fluorescence
detected by triple-channel confocal laser scanning micro-
scopy (Fig. 6). The cellular localization was very similar for
all peptides, with a homogeneously distributed fluorescence
present in the cytoplasm and in the nucleus and a vesicular
pattern of fluorescence in the extra-nuclear region of the
cell. In comparison to the fluorescein- and S0387-labelled
peptides, the TAMRA-labelled peptide exhibited a stronger
tendency to accumulate in vesicular structures.
4. Discussion
4.1. Import efficiencies of fluorescent derivatives
For both the AntpHD and the MTS peptides, an inter-
nally labelled analogue was identified with an import
efficiency comparable to the efficiency of the respective
N-terminally labelled peptide. All peptides were generated
by solid-phase peptide synthesis. The internal label was
coupled to a lysine q-amino group with the fully side-chain
protected peptide still on the solid phase. For this reason,
once the peptide moiety is synthesized, the N terminus of a
fully side-chain protected peptide is available for extension
with a peptide cargo or non-peptide cargo molecule. Based
on this labelling strategy, we anticipate that fluorescently
labelled cell-permeable peptides will gain significance as
pharmacokinetic modifiers for small molecules that other-
wise do not penetrate the plasma membrane. The fluoro-
phore serves as the reporter group to quantitate import of the
small molecule.
Fig. 6. Simultaneous import of three different cell-permeable peptides. Carboxyfluorescein- (A), carboxytetramethylrhodamine- (B), and S0387-labelled (C)
AntpHD peptides were detected by multichannel confocal laser scanning microscopy of living cells. Cells were incubated with peptide at concentrations of 4, 1,
and 2 AM for the fluorescein-, TAMRA-, and S0387-labelled peptides, respectively, for 2 h at 37 jC. The rhodamine and S0387 channel were virtually free of
cross-talk as determined from control samples loaded with either fluorescein- or TAMRA-labelled peptides, alone. The bar denotes 10 Am.
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Import of AntpHD analogues was more efficient than
import of MTS analogues by a factor of about 3. So far, only
few reports exist in which the import competence of differ-
ent sequence motifs were compared relative to each other.
To our knowledge, no direct comparison of a purely
aliphatic motif, such as the MTS peptide, and an amphipatic
motif, such as the AntpHD peptide, has been presented so
far. One should note, however, that in our case a polyethy-
leneglycol building block was introduced at the C terminus
of the MTS peptide in order to increase the solubility in
aqueous buffers. In our hands, AntpHD is the preferred cell-
permeable tag because of the higher import efficiency,
higher solubility in aqueous buffers, and comparatively less
adsorption to the walls of the measurement chambers [27].
By introduction of fluorophores within the central part of
the peptide sequence, constructs carrying a second fluoro-
phore either within the cargo or at the amino terminus of the
cargo may be generated. Such constructs may serve as cell-
permeable probes for intracellular protease activity by
detection of FRET [20] with optimised FRET character-
istics.
The abrogation of import of the AntpHD W6K(Fluo)
construct further substantiates the role of this specific side-
chain for import [2]. Interestingly, replacement with the
large aromatic fluorophore moiety had the same effect as
replacement with alanine. While import competence may be
conveyed by the general physicochemical characteristics of
the whole peptide [17], efficient uptake is strongly depend-
ent on the presence of structural determinants at specific
positions of the cell-permeable peptide. The finding that
only one out of four analogues derivatized with bulky
fluorophores at consecutive positions entered cells effi-
ciently supports the view that these peptides associate to a
biological membrane in a well-defined orientation [18,33].
The import efficiencies for AntpHD as well as for MTS
peptides labelled with the negatively charged carboxyfluo-
rescein strongly correlated with those labelled with the
zwitterionic carboxytetramethylrhodamine. This finding
supports the notion that for these two cell-permeable peptide
motifs, efficient uptake is a function of the peptide structure
rather than the overall physicochemical characteristic. Sur-
prisingly, the introduction of the negatively charged fluo-
rescein moiety in the central part of the strongly basic
AntpHD peptide was compatible with efficient import.
Recently, we introduced FCM for a direct determination
of intracellular peptide concentrations [27]. The determina-
tion of partition coefficients for cellular uptake by FCM
revealed that import of the TAMRA-labelled analogues was
slightly more efficient than that of the fluorescein-labelled
analogues. From the correlation of import efficiencies, we
conclude, however, that this effect must be very similar for
all TAMRA derivatives. Comparison of the cellular distri-
bution of fluorescein and TAMRA-labelled peptides having
no intrinsic transcytosis capacity has shown that the
TAMRA label may promote accumulation of these peptides
in vesicular structures by itself (own unpublished data). This
dye-dependent contribution may provide an explanation for
the generally higher import efficiency of TAMRA- over
fluorescein-labelled peptides. One should note that FCM is
the only technique capable of comparing import efficiencies
for cell-permeable substances labelled with different fluo-
rophores that does not depend on cumbersome calibration
procedures to normalize on the detection efficiencies for
different spectral ranges.
Comparison of import efficiencies determined by FCM
and flow cytometry demonstrated a concentration independ-
ence of import from the lower micromolar to the lower
nanomolar range. So far, the analysis of the concentration
dependence of import has been limited from the higher
nanomolar to the mean micromolar range [1,16,34]. That
large of a concentration range could only be covered by
combination of these two analytical techniques. Flow
cytometry is too insensitive to quantitate import in the lower
nanomolar range, while FCM can only be used at lower
nanomolar concentrations.
To further extend the spectral range of fluorescent cell-
permeable peptide derivatives, an N-terminal analogue of
AntpHD labelled with the indocyanine dye S0387 was
generated and the intracellular distribution investigated with
confocal laser scanning microscopy. In this way we were
able to demonstrate the simultaneous detection of three
different cell-permeable peptide constructs. In all cases, a
vesicular staining was present that was the most pronounced
for the TAMRA-labelled derivative. So far the nature of the
vesicles has not been addressed. The vesicular accumulation
of the cell-permeable peptides will present some limitation
in the analysis of a cargo-driven subcellular targeting of
cell-permeable peptide constructs, e.g. to target molecules
present in specific cellular compartments. Our data indicate
that TAMRA will be the least suited fluorophore for this
kind of application.
4.2. Cargo dependence of import
The independence of import on the nature of the fluo-
rophore was contrasted by a marked dependence on the
peptide cargo. Even though all peptides investigated were
very similar in size, ranging from 8 to 10 amino acids,
import efficiencies varied by as much as a factor of 8 for the
Myc-tag peptide and for the ZAP-70 inhibitor peptide.
While the Myc-tag peptide is characterised by a negative
net charge of three, the AntpHD-conjugated SIINFEKL-
epitope carries one negative net charge, and the ZAP-70
inhibitor peptide is strongly hydrophobic with a neutral net
charge. Apparently, a strong negative correlation exists
between the negative charge of the cargo and the import
efficiency. So far, this observation has only been reported
for the transcytosis sequence alone [29]. The effect that
subtle structural changes may have on uptake was addressed
using a truncated analogue of the penetratin peptide. For the
import peptide alone, as much as for a conjugate with the
ZAP-70 inhibitor peptide, C-terminal amidation greatly
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affected the import efficiency. Interestingly, the truncated
peptide alone was very inefficient in cellular import when
compared with the full-length penetratin peptide. Previ-
ously, this peptide was shown to possess about 60% of
the translocation efficiency of the full-length Antennapedia
peptide [16]. This discrepancy may result from the differ-
ences in assay conditions. In the initial report, a biotinylated
analogue was employed and cells were labelled with fluo-
rescently labelled streptavidin after fixation. Fixation, how-
ever, may lead to a loss of small molecules due to poor
cross-linking. It cannot be excluded that only a fraction of
molecules, e.g. those present in vesicular structures, were
retained in the cells while the major part of those present in
the cytoplasm and nucleus were lost. For this reason, all
analyses in our report were based on fluorescence in living
cells. In one of the initial analyses of the structure–activity
relationship of the AntpHD peptide, Derossi et al. [2]
reported that removal of only two amino acids from either
the N or C terminus abolished import. For the truncated
peptide, import competence was rescued by conjugation of
the highly hydrophobic cargo KLILFLLL. It seems that in
this case, the cargo complements the cell-permeable moiety.
In summary, attachment of fluorophores that differed
markedly in their physicochemical characteristics was tol-
erated surprisingly well. Import depended much more on the
cargo than on the nature of the fluorophore. Analysis of
import by FCM revealed that the concentrations in the
buffer did not reflect the concentrations of these molecules
inside the cells. Both findings stress the need for a detailed
monitoring of intracellular peptide concentrations in appli-
cations such as the analysis of structure function relation-
ships and quantitatively controlled inhibition of intracellular
processes. The fluorescent peptide analogues identified in
this study provide the tools for that purpose.
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